Combination of enmetazobactam, invented by scientists associated with Chennai-based pharma firm Orchid Pharma in 2008, and ...
Amgen’s Bkemv is the first interchangeable biosimilar to Soliris to treat certain rare diseases. The treatment of patients ...
The U.S. Food and Drug Administration approved on Tuesday Amgen's Bkemv, the first biosimilar to AstraZeneca's rare blood ...
Uplizna also hit the target on a number of secondary measures, including: annualised flare rate; flare-free, treatment-free ...
Amgen Inc (NASDAQ:AMGN) announced topline results from its Phase 3 trial evaluating the efficacy and safety of Uplizna ...
Amgen has made waves in the biosimilar field in recent years with its U.S.-first Humira biosim launch last year and its ...
Uplizna is currently approved in the U.S., Europe and Canada, among others, for a rare, severe, neuroinflammatory disease ...
Amgen latest news, photos, videos, breaking news, special reports, blogs, and updates from Business Insider India ...
US FDA approves first interchangeable biosimilar to treat certain rare diseases: Silver Spring, Maryland Thursday, May 30, 2024, 13:00 Hrs [IST] The US Food and Drug Administratio ...
The world's first human trial of a drug designed to regenerate real teeth is set to commence in jus… ...
AbbVie ABBV dosed the first patient with ABBV-383, an investigational BCMA-CD3-targeted bispecific antibody, in the phase III ...
The US Food and Drug Administration approved Cambridge, Massachusetts-based Moderna’s vaccine for a respiratory virus which ...